Hancock KC - Search Results

1

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.

Oh J, Barve M, Matthews CM, Koon EC, Heffernan TP, Fine B, Grosen E, Bergman MK, Fleming EL, DeMars LR, West L, Spitz DL, Goodman H, Hancock KC, Wallraven G, Kumar P, Bognar E, Manning L, Pappen BO, Adams N, Senzer N, Nemunaitis J. Oh J, et al. Among authors: hancock kc. Gynecol Oncol. 2016 Dec;143(3):504-510. doi: 10.1016/j.ygyno.2016.09.018. Epub 2016 Sep 24. Gynecol Oncol. 2016. PMID: 27678295 Clinical Trial.

2

Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.

Gordon AN, Hancock KC, Matthews CM, Messing M, Stringer CA, Doherty MG, Teneriello M. Gordon AN, et al. Among authors: hancock kc. Gynecol Oncol. 2002 Apr;85(1):129-35. doi: 10.1006/gyno.2001.6581. Gynecol Oncol. 2002. PMID: 11925132 Clinical Trial.

3

A phase I/II dose escalation study of carboplatin in the treatment of newly diagnosed patients with advanced ovarian cancer receiving paclitaxel.

Gordon AN, Hancock KC, Matthews CM, Stringer CA, Boston J, Nemunaitis J. Gordon AN, et al. Among authors: hancock kc. Am J Clin Oncol. 1999 Dec;22(6):601-5. doi: 10.1097/00000421-199912000-00011. Am J Clin Oncol. 1999. PMID: 10597745 Clinical Trial.

4

A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer.

Friedlander M, Hancock KC, Rischin D, Messing MJ, Stringer CA, Matthys GM, Ma B, Hodge JP, Lager JJ. Friedlander M, et al. Among authors: hancock kc. Gynecol Oncol. 2010 Oct;119(1):32-7. doi: 10.1016/j.ygyno.2010.05.033. Epub 2010 Jun 27. Gynecol Oncol. 2010. PMID: 20584542 Clinical Trial.

5

Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer.

Teneriello MG, Tseng PC, Crozier M, Encarnacion C, Hancock K, Messing MJ, Boehm KA, Williams A, Asmar L. Teneriello MG, et al. J Clin Oncol. 2009 Mar 20;27(9):1426-31. doi: 10.1200/JCO.2008.18.9548. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224848 Clinical Trial.

6

Urethral placement through a bilateral myocutaneous gracilis flap neovagina.

Wheelock JB, Hancock K. Wheelock JB, et al. Gynecol Oncol. 1989 Jan;32(1):88-90. doi: 10.1016/0090-8258(89)90858-5. Gynecol Oncol. 1989. PMID: 2909455

7

Relapsing Clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy.

Satin AJ, Harrison CR, Hancock KC, Zahn CM. Satin AJ, et al. Among authors: hancock kc. Obstet Gynecol. 1989 Sep;74(3 Pt 2):487-9. Obstet Gynecol. 1989. PMID: 2761938

8

Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenteration.

Copeland LJ, Hancock KC, Gershenson DM, Stringer CA, Atkinson EN, Edwards CL. Copeland LJ, et al. Among authors: hancock kc. Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1095-101. doi: 10.1016/0002-9378(89)90168-3. Am J Obstet Gynecol. 1989. PMID: 2658602

9

Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary.

Wheelock J, Hancock K, Smith K. Wheelock J, et al. Cancer Treat Rep. 1987 Dec;71(12):1275-6. Cancer Treat Rep. 1987. PMID: 3690537 No abstract available.

10

Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.

Hancock KC, Freedman RS, Edwards CL, Rutledge FN. Hancock KC, et al. Cancer Treat Rep. 1986 Jun;70(6):789-91. Cancer Treat Rep. 1986. PMID: 3731140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page